Healthcare provider profile · identity verified

Crystal B Gary, MD

Family Practice · BLAIRSVILLE, GA · NPI 1154405207

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	374	82
Atorvastatin Calcium	Atorvastatin Calcium	269	71
Losartan Potassium	Losartan Potassium	230	62
Amlodipine Besylate	Amlodipine Besylate	214	58
Rosuvastatin Calcium	Rosuvastatin Calcium	187	58
Omeprazole	Omeprazole	166	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	160	35
Gabapentin	Gabapentin	146	34
Metoprolol Succinate	Metoprolol Succinate	134	38
Hydrochlorothiazide	Hydrochlorothiazide	129	36
Sertraline Hcl	Sertraline Hcl	128	34
Trazodone Hcl	Trazodone Hcl	119	27
Lisinopril	Lisinopril	116	34
Tramadol Hcl	Tramadol Hcl	116	24
Metformin Hcl	Metformin Hcl	111	29
Metoprolol Tartrate	Metoprolol Tartrate	104	29
Prednisone	Prednisone	103	73
Alprazolam	Alprazolam	96	21
Duloxetine Hcl	Duloxetine Hcl	87	12
Fluoxetine Hcl	Fluoxetine Hcl	82	24
Furosemide	Furosemide	81	24
Ozempic	Semaglutide	77	12
Zolpidem Tartrate	Zolpidem Tartrate	77	18
Bupropion Xl	Bupropion Hcl	74	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	20
Meloxicam	Meloxicam	68	20
Potassium Chloride	Potassium Chloride	68	23
Estradiol	Estradiol	67	14
Pantoprazole Sodium	Pantoprazole Sodium	63	20
Valsartan	Valsartan	63	16
Jardiance	Empagliflozin	60	suppressed
Citalopram Hbr	Citalopram Hydrobromide	57	12
Azithromycin	Azithromycin	53	43
Paroxetine Hcl	Paroxetine Hcl	53	12
Simvastatin	Simvastatin	53	15
Mounjaro	Tirzepatide	51	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	32
Ezetimibe	Ezetimibe	50	16
Glimepiride	Glimepiride	49	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	13
Solifenacin Succinate	Solifenacin Succinate	48	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	19
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Celecoxib	Celecoxib	41	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	29
Fluconazole	Fluconazole	39	21
Lorazepam	Lorazepam	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	14
Atenolol	Atenolol	36	suppressed
Eliquis	Apixaban	36	suppressed
Ondansetron Odt	Ondansetron	35	17
Carvedilol	Carvedilol	34	11
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	26
Trulicity	Dulaglutide	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	16
Temazepam	Temazepam	25	suppressed
Liothyronine Sodium	Liothyronine Sodium	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Amoxicillin	Amoxicillin	18	16
Donepezil Hcl	Donepezil Hcl	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Metformin Er Gastric	Metformin Hcl	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Armour Thyroid	Thyroid,pork	16	suppressed
Diazepam	Diazepam	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Nystatin	Nystatin	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Modafinil	Modafinil	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Famotidine	Famotidine	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	12	suppressed
Tegretol	Carbamazepine	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Vimpat	Lacosamide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Restasis	Cyclosporine	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Topiramate	Topiramate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error